{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:42:25Z","timestamp":1790800945854,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Cluster of Excellence 171"],"award-info":[{"award-number":["Cluster of Excellence 171"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12017-017-8447-9","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T14:18:03Z","timestamp":1497622683000},"page":"309-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1354-1239","authenticated-orcid":false,"given":"Eleonora","family":"Carboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tatenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"T\u00f6nges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Barski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Dambeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"B\u00e4hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"issue":"11","key":"8447_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3324\/haematol.2011.043018","volume":"96","author":"G Abbruzzese","year":"2011","unstructured":"Abbruzzese, G., Cossu, G., Balocco, M., Marchese, R., Murgia, D., Melis, M., et al. (2011). A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica, 96(11), 1708\u20131711. doi: 10.3324\/haematol.2011.043018 .","journal-title":"Haematologica"},{"issue":"6","key":"8447_CR2","doi-asserted-by":"publisher","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","volume":"7","author":"E Angot","year":"2012","unstructured":"Angot, E., Steiner, J. A., Lema Tom\u00e9, C. M., Ekstr\u00f6m, P., Mattsson, B., Bj\u00f6rklund, A., et al. (2012). Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS ONE, 7(6), e39465. doi: 10.1371\/journal.pone.0039465 .","journal-title":"PLoS ONE"},{"issue":"1","key":"8447_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2014.12.052","volume":"588","author":"T Asano","year":"2015","unstructured":"Asano, T., Koike, M., Sakata, S. I., Takeda, Y., Nakagawa, T., Hatano, T., et al. (2015). Possible involvement of iron-induced oxidative insults in neurodegeneration. Neuroscience Letters, 588(1), 29\u201335. doi: 10.1016\/j.neulet.2014.12.052 .","journal-title":"Neuroscience Letters"},{"issue":"1","key":"8447_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","volume":"18","author":"SR Bareggi","year":"2012","unstructured":"Bareggi, S. R., & Cornelli, U. (2012). Clioquinol: Review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neuroscience & Therapeutics, 18(1), 41\u201346. doi: 10.1111\/j.1755-5949.2010.00231.x .","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"3","key":"8447_CR5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/nprot.2006.205","volume":"1","author":"RA Bevins","year":"2006","unstructured":"Bevins, R. A., & Besheer, J. (2006). Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study \u201crecognition memory\u201d. Nature Protocols, 1(3), 1306\u20131311. doi: 10.1038\/nprot.2006.205 .","journal-title":"Nature Protocols"},{"issue":"3","key":"8447_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acschemneuro.5b00305","volume":"7","author":"JL Billings","year":"2016","unstructured":"Billings, J. L., Hare, D. J., Nurjono, M., Volitakis, I., Cherny, R. A., Bush, A. I., et al. (2016). Effects of neonatal iron feeding and chronic clioquinol administration on the Parkinsonian human A53T transgenic mouse. ACS Chemical Neuroscience, 7(3), 360\u2013366. doi: 10.1021\/acschemneuro.5b00305 .","journal-title":"ACS Chemical Neuroscience"},{"issue":"30","key":"8447_CR7","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1021\/ja0618649","volume":"128","author":"A Binolfi","year":"2006","unstructured":"Binolfi, A., Rasia, R. M., Bertoncini, C. W., Ceolin, M., Zweckstetter, M., Griesinger, C., et al. (2006). Interaction of alpha-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity and fibrillation enhancement 21. Journal of the American Chemical Society, 128(30), 9893\u20139901. doi: 10.1021\/ja0618649 .","journal-title":"Journal of the American Chemical Society"},{"issue":"5","key":"8447_CR8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/JVI.62.5.1558-1564.1988","volume":"62","author":"DA Butler","year":"1988","unstructured":"Butler, D. A., Scott, M. R., Bockman, J. M., Borchelt, D. R., Taraboulos, A., Hsiao, K. K., et al. (1988). Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. Journal of Virology, 62(5), 1558\u20131564.","journal-title":"Journal of Virology"},{"issue":"December","key":"8447_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2013.00167","volume":"4","author":"ZI Cabantchik","year":"2013","unstructured":"Cabantchik, Z. I., Munnich, A., Youdim, M. B., & Devos, D. (2013). Regional siderosis: A new challenge for iron chelation therapy. Frontiers in Pharmacology, 4(December), 167. doi: 10.3389\/fphar.2013.00167 .","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"8447_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004010050001","volume":"100","author":"RJ Castellani","year":"2000","unstructured":"Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000). Sequestration of iron by Lewy bodies in Parkinson\u2019s disease. Acta Neuropathologica, 100(2), 111\u2013114. doi: 10.1007\/s004010050001 .","journal-title":"Acta Neuropathologica"},{"key":"8447_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1152\/ajpcell.00541.2007","volume":"294","author":"RA Colvin","year":"2008","unstructured":"Colvin, R. A., Bush, A. I., Volitakis, I., Fontaine, C. P., Thomas, D., Kikuchi, K., et al. (2008). Insights into Zn2+ homeostasis in neurons from experimental and modeling studies. American Journal of Physiology-Cell Physiology, 294, 726\u2013742. doi: 10.1152\/ajpcell.00541.2007 .","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"2","key":"8447_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., et al. (2014). Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxidants & Redox Signaling, 21(2), 195\u2013210. doi: 10.1089\/ars.2013.5593 .","journal-title":"Antioxidants & Redox Signaling"},{"issue":"6","key":"8447_CR13","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter, D. T., Wells, F. R., Lees, A. J., Agid, F., Agid, Y., Jenner, P., et al. (1989). Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. Journal of Neurochemistry, 52(6), 1830\u20131836. doi: 10.1111\/j.1471-4159.1989.tb07264.x .","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"8447_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/0883073816636087","volume":"31","author":"S Elincx-Benizri","year":"2016","unstructured":"Elincx-Benizri, S., Glik, A., Merkel, D., Arad, M., Freimark, D., Kozlova, E., et al. (2016). Clinical experience with deferiprone treatment for Friedreich ataxia. Journal of Child Neurology, 31(8), 1036\u20131040. doi: 10.1177\/0883073816636087 .","journal-title":"Journal of Child Neurology"},{"issue":"1","key":"8447_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acschemneuro.5b00253","volume":"7","author":"DI Finkelstein","year":"2016","unstructured":"Finkelstein, D. I., Hare, D. J., Billings, J. L., Sedjahtera, A., Nurjono, M., Arthofer, E., et al. (2016). Clioquinol improves cognitive, motor function, and microanatomy of the alpha-synuclein hA53T transgenic mice. ACS Chemical Neuroscience, 7(1), 119\u2013129. doi: 10.1021\/acschemneuro.5b00253 .","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"8447_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0300-483X(95)03301-U","volume":"108","author":"AM Fredenburg","year":"1996","unstructured":"Fredenburg, A. M., Sethi, R. K., Allen, D. D., & Yokel, R. A. (1996). The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1-ol]-2-methyl-3-hydroxypyridin-4-one in the rat. Toxicology, 108(3), 191\u2013199. doi: 10.1016\/0300-483X(95)03301-U .","journal-title":"Toxicology"},{"issue":"1","key":"8447_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/taap.1999.8711","volume":"159","author":"A Fredriksson","year":"1999","unstructured":"Fredriksson, A., Schr\u00f6der, N., Eriksson, P., Izquierdo, I., & Archer, T. (1999). Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicology and Applied Pharmacology, 159(1), 25\u201330. doi: 10.1006\/taap.1999.8711 .","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"5","key":"8447_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","volume":"62","author":"C Funke","year":"2013","unstructured":"Funke, C., Schneider, S. A., Berg, D., & Kell, D. B. (2013). Genetics and iron in the systems biology of Parkinson\u2019s disease and some related disorders. Neurochemistry International, 62(5), 637\u2013652. doi: 10.1016\/j.neuint.2012.11.015 .","journal-title":"Neurochemistry International"},{"issue":"5","key":"8447_CR19","first-page":"795","volume":"3","author":"R Galanello","year":"2007","unstructured":"Galanello, R. (2007). Deferiprone in the treatment of transfusion-dependent thalassemia: A review and perspective. Therapeutics and Clinical Risk Management, 3(5), 795\u2013805.","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"4","key":"8447_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002). Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron, 34(4), 521\u2013533. doi: 10.1016\/S0896-6273(02)00682-7 .","journal-title":"Neuron"},{"issue":"18","key":"8447_CR21","doi-asserted-by":"publisher","first-page":"16116","DOI":"10.1074\/jbc.M107866200","volume":"277","author":"N Golts","year":"2002","unstructured":"Golts, N. (2002). Magnesium inhibits spontaneous and iron-induced aggregation of alpha -synuclein. Journal of Biological Chemistry, 277(18), 16116\u201316123. doi: 10.1074\/jbc.M107866200 .","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"8447_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","volume":"20","author":"BJ Jones","year":"1968","unstructured":"Jones, B. J., & Roberts, D. J. (1968). The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod. The Journal of Pharmacy and Pharmacology, 20(4), 302\u2013304. doi: 10.1111\/j.2042-7158.1968.tb09743.x .","journal-title":"The Journal of Pharmacy and Pharmacology"},{"issue":"9996","key":"8447_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V., & Lang, A. E. (2015). Parkinson\u2019s disease. Lancet (London, England), 386(9996), 896\u2013912. doi: 10.1016\/S0140-6736(14)61393-3 .","journal-title":"Lancet (London, England)"},{"issue":"6","key":"8447_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/mds.25499","volume":"28","author":"M Kasten","year":"2013","unstructured":"Kasten, M., & Klein, C. (2013). The many faces of alpha-synuclein mutations. Movement Disorders, 28(6), 697\u2013701. doi: 10.1002\/mds.25499 .","journal-title":"Movement Disorders"},{"issue":"6","key":"8447_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neurobiolaging.2006.04.003","volume":"28","author":"D Kaur","year":"2007","unstructured":"Kaur, D., Peng, J., Chinta, S. J., Rajagopalan, S., Di Monte, D. A., Cherny, R. A., et al. (2007). Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiology of Aging, 28(6), 907\u2013913. doi: 10.1016\/j.neurobiolaging.2006.04.003 .","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"8447_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., et al. (2003). Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo. Neuron, 37(6), 899\u2013909. doi: 10.1016\/S0896-6273(03)00126-0 .","journal-title":"Neuron"},{"issue":"5","key":"8447_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C., Kehm, V. M., Zhang, B., O\u2019Brien, P., Trojanowski, J. Q., & Lee, V. M. Y. (2012). Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. The Journal of Experimental Medicine, 209(5), 975\u2013986. doi: 10.1084\/jem.20112457 .","journal-title":"The Journal of Experimental Medicine"},{"issue":"1\u20133","key":"8447_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2008.08.015","volume":"182","author":"X Mao","year":"2008","unstructured":"Mao, X., & Schimmer, A. D. (2008). The toxicology of clioquinol. Toxicology Letters, 182(1\u20133), 1\u20136. doi: 10.1016\/j.toxlet.2008.08.015 .","journal-title":"Toxicology Letters"},{"key":"8447_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2013.11.007","volume":"63","author":"E Mutez","year":"2014","unstructured":"Mutez, E., Nkiliza, A., Belarbi, K., de Broucker, A., Vanbesien-Mailliot, C., Bleuse, S., et al. (2014). Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson\u2019s disease. Neurobiology of Disease, 63, 165\u2013170. doi: 10.1016\/j.nbd.2013.11.007 .","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"8447_CR30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.1988.38.181","volume":"38","author":"JJ Oprandy","year":"1988","unstructured":"Oprandy, J. J., Olson, J. G., & Scott, T. W. (1988). A rapid dot immunoassay for the detection of serum antibodies to eastern equine encephalomyelitis and St. Louis encephalitis viruses in sentinel chickens. The American Journal of Tropical Medicine and Hygiene, 38(1), 181\u2013186.","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"8447_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jinorgbio.2009.11.005","volume":"104","author":"Y Peng","year":"2010","unstructured":"Peng, Y., Wang, C., Xu, H. H., Liu, Y. N., & Zhou, F. (2010). Binding of \u03b1-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. Journal of Inorganic Biochemistry, 104(4), 365\u2013370. doi: 10.1016\/j.jinorgbio.2009.11.005 .","journal-title":"Journal of Inorganic Biochemistry"},{"issue":"3","key":"8447_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/157340708786305952.Iron","volume":"4","author":"C Perez","year":"2008","unstructured":"Perez, C., Tong, Y., & Guo, M. (2008). Iron chelators as potential therapeutic agents for Parkinson\u2019s disease. Current Bioactive Compounds, 4(3), 150\u2013158. doi: 10.2174\/157340708786305952.Iron .","journal-title":"Current Bioactive Compounds"},{"issue":"5321","key":"8447_CR33","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science (New York, N.Y.), 276(5321), 2045\u20132047.","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"8447_CR34","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/glia.21172.Central","volume":"59","author":"KA Potter","year":"2011","unstructured":"Potter, K. A., Kern, M. J., Fullbright, G., Bielawski, J., Steven, S., Yum, S. W., et al. (2011). Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia, 59(7), 1009\u20131021. doi: 10.1002\/glia.21172.Central .","journal-title":"Glia"},{"issue":"13","key":"8447_CR35","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014). The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis. Movement Disorders, 29(13), 1583\u20131590. doi: 10.1002\/mds.25945 .","journal-title":"Movement Disorders"},{"key":"8447_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2014.09.013","volume":"73","author":"K-A Saal","year":"2015","unstructured":"Saal, K.-A., Koch, J. C., Tatenhorst, L., Szeg\u0151, E. M., Ribas, V. T., Michel, U., et al. (2015). AAV. shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson\u2019s disease in vitro and in vivo. Neurobiology of Disease, 73, 150\u2013162. doi: 10.1016\/j.nbd.2014.09.013 .","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"8447_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton, A. B., Farrer, M. J., & Bonifati, V. (2013). The genetics of Parkinson\u2019s disease: progress and therapeutic implications. Movement Disorders : Official Journal of the Movement Disorder Society, 28(1), 14\u201323. doi: 10.1002\/mds.25249 .","journal-title":"Movement Disorders : Official Journal of the Movement Disorder Society"},{"issue":"2B","key":"8447_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1476-5381.2010.01120.x","volume":"164","author":"YS Sohn","year":"2011","unstructured":"Sohn, Y. S., Mitterstiller, A. M., Breuer, W., Weiss, G., & Cabantchik, Z. I. (2011). Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal. British Journal of Pharmacology, 164(2B), 406\u2013418. doi: 10.1111\/j.1476-5381.2010.01120.x .","journal-title":"British Journal of Pharmacology"},{"issue":"6645","key":"8447_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839\u2013840. doi: 10.1038\/42166 .","journal-title":"Nature"},{"issue":"1","key":"8447_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0085115","volume":"9","author":"J Sripetchwandee","year":"2014","unstructured":"Sripetchwandee, J., Pipatpiboon, N., Chattipakorn, N., & Chattipakorn, S. (2014). Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity. PLoS ONE, 9(1), 1\u201315. doi: 10.1371\/journal.pone.0085115 .","journal-title":"PLoS ONE"},{"issue":"1","key":"8447_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40478-016-0310-y","volume":"4","author":"L Tatenhorst","year":"2016","unstructured":"Tatenhorst, L., Eckermann, K., Dambeck, V., Fonseca-Ornelas, L., Walle, H., Lopes da Fonseca, T., et al. (2016). Fasudil attenuates aggregation of \u03b1-synuclein in models of Parkinson\u2019s disease. Acta Neuropathologica Communications, 4(1), 39. doi: 10.1186\/s40478-016-0310-y .","journal-title":"Acta Neuropathologica Communications"},{"issue":"8","key":"8447_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","volume":"73","author":"L Tatenhorst","year":"2014","unstructured":"Tatenhorst, L., T\u00f6nges, L., Saal, K.-A., Koch, J. C., Szeg\u0151, E. M., B\u00e4hr, M., et al. (2014). Rho kinase inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease. Journal of Neuropathology and Experimental Neurology, 73(8), 770\u2013779. doi: 10.1097\/NEN.0000000000000095 .","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"8447_CR44","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1093\/brain\/aws254","volume":"135","author":"L T\u00f6nges","year":"2012","unstructured":"T\u00f6nges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, \u00c9. M., et al. (2012). Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson\u2019s disease. Brain, 135, 3355\u20133370. doi: 10.1093\/brain\/aws254 .","journal-title":"Brain"},{"key":"8447_CR45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","volume":"62","author":"O Weinreb","year":"2013","unstructured":"Weinreb, O., Mandel, S., Youdim, M. B. H., & Amit, T. (2013). Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators. Free Radical Biology and Medicine, 62, 52\u201364. doi: 10.1016\/j.freeradbiomed.2013.01.017 .","journal-title":"Free Radical Biology and Medicine"},{"key":"8447_CR46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1039\/C4MT00326H","volume":"7","author":"DG Workman","year":"2015","unstructured":"Workman, D. G., Tsatsanis, A., Lewis, F. W., Boyle, J. P., Mousadoust, M., Hettiarachchi, N. T., et al. (2015). Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson\u2019s with novel 1-hydroxypyridin-2-one metal chelators. Metallomics, 7, 867\u2013876. doi: 10.1039\/C4MT00326H .","journal-title":"Metallomics"},{"key":"8447_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2013.12.015","volume":"68","author":"ZD Zhou","year":"2014","unstructured":"Zhou, Z. D., Refai, F. S., Xie, S. P., Ng, S. H., Chan, C. H. S., Ho, P. G. H., et al. (2014). Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons. Free Radical Biology and Medicine, 68, 220\u2013233. doi: 10.1016\/j.freeradbiomed.2013.12.015 .","journal-title":"Free Radical Biology and Medicine"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-017-8447-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-017-8447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-017-8447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:53:37Z","timestamp":1602320017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-017-8447-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":46,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["8447"],"URL":"https:\/\/doi.org\/10.1007\/s12017-017-8447-9","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]}}}